2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"

By ecancer FEATURING Robert Jotte
By ecancer FEATURING Robert Jotte
194 views
June 21, 2024
Comments 0
Login to view comments. Click here to Login